Azora Therapeutics, Inc (AZR)

Currency in USD
3.710
-0.340(-8.40%)
Closed·
3.7100.000(0.00%)
·
Earnings results expected in 12 days
AZR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.7104.040
52 wk Range
1.3108.750
Key Statistics
Prev. Close
3.71
Open
4.04
Day's Range
3.71-4.04
52 wk Range
1.31-8.75
Volume
18.55K
Average Volume (3m)
54.49K
1-Year Change
-54.6177%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AZR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
13.000
Upside
+250.40%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Azora Therapeutics, Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 13.000
(+250.40% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Alliance Global Partners
Buy11.00+196.50%-New CoverageAug 03, 2026
Lucid Capital Markets
Buy6.00+61.73%-New CoverageJun 15, 2026
Maxim Group
Buy8.00+115.63%37.50MaintainFeb 11, 2026

Earnings

Latest Release
Aug 17, 2026
EPS / Forecast
-11.25 / -1.07
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare AZR to Peers and Sector

Metrics to compare
AZR
Peers
Sector
Relationship
P/E Ratio
0.0x−0.3x−0.2x
PEG Ratio
0.00−0.010.00
Price/Book
0.0x0.0x2.6x
Price / LTM Sales
0.0x1.1x2.8x
Upside (Analyst Target)
250.4%120.6%62.1%
Fair Value Upside
Unlock26.6%9.5%Unlock

Azora Therapeutics, Inc. operates as a biopharmaceutical company that develops small molecule new chemical entities for the treatment of autoimmune and inflammatory diseases. It offers treatment for dermatology and gastroenterology. The company's pipeline includes AT177, a colon-targeted aryl hydrocarbon receptor (AhR) agonist to enable localized activation with limited systemic exposure in development for ulcerative colitis. Azora Therapeutics, Inc. was formerly known as Meya Pharmaceuticals, Inc. and changed its name to Azora Therapeutics, Inc. in March 2019. The company was incorporated in 2017 and is based in Encino, California.

People Also Watch

0.616
ALDX
-4.79%
1.840
TCRT
+2.22%
0.356
EYPT
-9.87%
37.68
XENE
-3.85%

FAQ

What Is the Azora (AZR) Stock Price Today?

The Azora stock price today is 3.710 USD.

What Stock Exchange Does Azora Trade On?

Azora is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Azora?

The stock symbol for Azora is "AZR."

What Is the Azora Market Cap?

As of today, Azora market cap is 9.740M USD.

When Is the Next Azora Earnings Date?

Azora will release its next earnings report on Nov 18, 2026.

From a Technical Analysis Perspective, Is AZR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Azora Stock Split?

Azora has split 2 times.

What is the current trading status of Azora (AZR)?

As of Nov 06, 2026, Azora (AZR) is trading at a price of 3.710 USD, with a previous close of 3.710 USD. The stock has fluctuated within a day range of 3.710 USD to 4.040 USD, while its 52-week range spans from 1.310 USD to 8.750 USD.

What Is Azora (AZR) Price Target According to Analysts?

The average 12-month price target for Azora is 13.000 USD, with a high estimate of 14 USD and a low estimate of 12 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +250.40% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.